REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 111 filers reported holding REVANCE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,671,094 | -10.4% | 1,366,268 | +97.8% | 0.05% | -11.5% |
| Q2 2023 | $17,484,983 | +3669.7% | 690,833 | +4697.5% | 0.05% | +5100.0% |
| Q1 2023 | $463,824 | -94.5% | 14,400 | -97.6% | 0.00% | -97.1% |
| Q2 2022 | $8,369,000 | -45.5% | 605,574 | -23.0% | 0.04% | -42.6% |
| Q1 2022 | $15,346,000 | +6.7% | 786,967 | -10.7% | 0.06% | +7.0% |
| Q4 2021 | $14,386,000 | -31.6% | 881,482 | +16.8% | 0.06% | -38.0% |
| Q3 2021 | $21,029,000 | +180.3% | 754,800 | +181.2% | 0.09% | +162.9% |
| Q1 2021 | $7,502,000 | +74.3% | 268,400 | +1.2% | 0.04% | +52.2% |
| Q4 2019 | $4,304,000 | +51.8% | 265,199 | +21.6% | 0.02% | +35.3% |
| Q3 2019 | $2,836,000 | +88.9% | 218,155 | +88.6% | 0.02% | +112.5% |
| Q2 2019 | $1,501,000 | – | 115,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $52,671,000 | 26.22% |
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $24,561,000 | 22.85% |
| Sio Capital Management, LLC | 254,581 | $4,012,000 | 1.08% |
| ArrowMark Colorado Holdings LLC | 3,409,217 | $53,729,000 | 0.51% |
| Fosun International Ltd | 472,532 | $7,447,000 | 0.47% |
| Rhenman & Partners Asset Management AB | 193,181 | $3,045,000 | 0.36% |
| Phoenix Investment Adviser LLC | 4,900 | $77,000 | 0.17% |
| HARBOURVEST PARTNERS LLC | 26,565 | $419,000 | 0.15% |
| Quinn Opportunity Partners LLC | 56,672 | $893,000 | 0.12% |
| MFN Partners Management, LP | 46,000 | $725,000 | 0.12% |